Company intelligence / Profile preview

QSTAG

Ownership: Private
Development stage: Other

Overview

QSTAG has commercialized its smart urine tester, QSCHECK-UIS, enabling at-home urinalysis for glucose, blood, protein, and pH. The product leverages QR code-enabled strips analyzed by a mobile app for improved accuracy over traditional colorimetric strips. The company is also developing more advanced immunology-based diagnostic kits but these are still in R&D.

Therapeutic areas: EndocrinologyInfectious DiseasesOther
Modalities: DeviceBiosensor-based diagnostic kitPoint-of-care testing (POCT) technology
Industry: Consumable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on QSTAG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QSTAG.

Explore the full profile